TY - JOUR
T1 - HPLC-MS profiling and protective potential of the defatted aqueous methanol extract of two Syzygium species against cadmium chloride-induced nephrotoxicity in rats
AU - Moharram, Fatma A.
AU - Salem, Sahar S.
AU - Shabana, Samah
AU - El-Sayed, Elsayed K.
AU - Mohamed, Shimaa K.
AU - Khattab, Mohamed A.
AU - Lai, Kuei Hung
AU - Ahmed, Asmaa A.
AU - Elsayed, Heba E.
N1 - Publisher Copyright:
© 2025 Moharram et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2025/8
Y1 - 2025/8
N2 - Cadmium (Cd), a highly toxic heavy metal, is used in food and agricultural products while displaying nephrotoxicity to animals and humans. The genus Syzygium (Myrtle family) is rich in precious phenolic metabolites with various therapeutic values. This study investigated the phenolic content and the therapeutic potential of the defatted 80% aqueous methanol extract (DE) of S. malaccense and S. samarangense leaves against Cd-induced kidney injury in rats for the first time. High-performance liquid chromatography-Mass spectrometry (HPLC-MS), in addition to Folin-Ciocalteu and aluminium chloride colourimetric methods, depicted the phenolic metabolites, total phenolic content, and total flavonoid content, respectively. The nephroprotective effect was investigated using fifty-six female Sprague Dawley rats divided into eight groups: control group, CdCl2-treated group (3 mg/kg/i.p/7 days), and three groups of each species treated with the DE (250, 500, and 1000 mg/kg/o.p., respectively). The phytochemical analysis revealed the richness of S. samarangense DE by phenolic and flavonoid content over S. malaccense. The HPLC-MS showed the tentative identification of sixty-two compounds, in positive and negative ionization modes, belonging to phenolic acids (1−6), flavonoids (7−52), and miscellaneous compounds (53−62). Both extracts were considered safe up to 5 g/kg. At the maximum tested dose (100 mg/Kg), the DEs significantly (p<0.001) boosted the levels of antioxidant markers by 3.3–6 fold, lessened the inflammatory indicators by 66.8%−75.1%, and reduced the apoptotic parameters by 45.4–73.3%, compared to the CdCl2-treated group. Additionally, the DEs maintained the mitochondrial function and inhibited autophagy via decreasing adenosine monophosphate-activated protein kinase by 49.2%−50.6%, and baclin-1 by 49.5%−56.1%. Additionally, the DEs increased the mammalian target of rapamycin (mTOR) by 4.7–4.9 fold. Additionally, the DE ameliorated CdCl2-induced elevations in serum ALT and AST, indicating a protective effect against systemic toxicity. Ultimately, the DE of S. malaccense and S. samarangense protect against Cd-induced nephrotoxicity that may be correlated to their abundant phenolic content. However, selecting suitable formulations and implementing clinical studies are among the future directions.
AB - Cadmium (Cd), a highly toxic heavy metal, is used in food and agricultural products while displaying nephrotoxicity to animals and humans. The genus Syzygium (Myrtle family) is rich in precious phenolic metabolites with various therapeutic values. This study investigated the phenolic content and the therapeutic potential of the defatted 80% aqueous methanol extract (DE) of S. malaccense and S. samarangense leaves against Cd-induced kidney injury in rats for the first time. High-performance liquid chromatography-Mass spectrometry (HPLC-MS), in addition to Folin-Ciocalteu and aluminium chloride colourimetric methods, depicted the phenolic metabolites, total phenolic content, and total flavonoid content, respectively. The nephroprotective effect was investigated using fifty-six female Sprague Dawley rats divided into eight groups: control group, CdCl2-treated group (3 mg/kg/i.p/7 days), and three groups of each species treated with the DE (250, 500, and 1000 mg/kg/o.p., respectively). The phytochemical analysis revealed the richness of S. samarangense DE by phenolic and flavonoid content over S. malaccense. The HPLC-MS showed the tentative identification of sixty-two compounds, in positive and negative ionization modes, belonging to phenolic acids (1−6), flavonoids (7−52), and miscellaneous compounds (53−62). Both extracts were considered safe up to 5 g/kg. At the maximum tested dose (100 mg/Kg), the DEs significantly (p<0.001) boosted the levels of antioxidant markers by 3.3–6 fold, lessened the inflammatory indicators by 66.8%−75.1%, and reduced the apoptotic parameters by 45.4–73.3%, compared to the CdCl2-treated group. Additionally, the DEs maintained the mitochondrial function and inhibited autophagy via decreasing adenosine monophosphate-activated protein kinase by 49.2%−50.6%, and baclin-1 by 49.5%−56.1%. Additionally, the DEs increased the mammalian target of rapamycin (mTOR) by 4.7–4.9 fold. Additionally, the DE ameliorated CdCl2-induced elevations in serum ALT and AST, indicating a protective effect against systemic toxicity. Ultimately, the DE of S. malaccense and S. samarangense protect against Cd-induced nephrotoxicity that may be correlated to their abundant phenolic content. However, selecting suitable formulations and implementing clinical studies are among the future directions.
UR - https://www.scopus.com/pages/publications/105013138072
UR - https://www.scopus.com/inward/citedby.url?scp=105013138072&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0329586
DO - 10.1371/journal.pone.0329586
M3 - Article
C2 - 40811634
AN - SCOPUS:105013138072
SN - 1932-6203
VL - 20
JO - PLoS ONE
JF - PLoS ONE
IS - 8 August
M1 - e0329586
ER -